Research out tonight from CSFB increasing their share price target to $5.10 based on the Phase 3 results.
Wonder what Wilson HTM will have to say tomorrow. They were one of the very early supporters of the company. ABN AMRO and Bell Potter have only recently got on the bandwagon so they all might try and outdo themselves with price upgrades.
Bell Potter's bio-tech analyst need a good bio-tech stock after their disappointment with Progen.
Whetu and gliontos..I know you've been following this for a long while....good work.
PXS Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
